US Patent Issued to Orchard Therapeutics (Europe) on June 23 for "Compositions and methods for modifying eukaryotic cells" (British, American Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,686, issued on June 23, was assigned to Orchard Therapeutics (Europe) Ltd. (London).

"Compositions and methods for modifying eukaryotic cells" was invented by Jia Wolfe (Winchester, Mass.) and Pervinder Sagoo (St Albans, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compositions and methods for modifying eukaryotic cells, for example, to express a transgene of interest and/or to produce an expanded population of cells ex vivo. Using the compositions and methods of the disclosure, a population of eukaryotic cells, such as a population of pluripotent cells (e.g., CD34+ hematopoietic stem or progenitor cells) may be ...